are oral glp-1 effective 📢 FDA approves Orforglipron, a once-daily receptor agonist that helps reduce appetite, slow gastric emptying, and increase glucose-dependent insulin secretion. #fda #orforglipron #diabetes #obesity GLP-1 receptor agonists | How

However, its broader regulatory status is complex - FDA has raised regulatory and safety concerns regarding certain BPC-157-related bulk substances used in compounding contexts, and classifications may vary by use, jurisdiction, and product category

This is a good thing because its soothing and antioxidant activity is a surface-level job anyway

Note: An Expression of Concern has been issued for this paper (PMID 34551989, 2021)

4 At the cellular level, tumor cells can rewire survival signaling pathways, upregulate drug efflux transporters, undergo epithelial-mesenchymal transition (EMT), and enter dormant states